Hydroxychloroquine – Beyond Malaria: Its Role in Rheumatology and COVID-19 – A Literature Review

Hydroxychloroquine (HCQ) is a long-established drug, initially used to treat malaria and later widely applied in autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). As an immunomodulatory agent, HCQ plays a crucial role in managing chronic inflammation. Des...

Full description

Saved in:
Bibliographic Details
Main Authors: Adam Jan Ząbek, Jakub Paweł Kuźniar, Emilia Gabriela Chrzanowska, Michalina Zagalska, Marta Turek, Tomasz Tamborski, Adam Grzebinoga, Julia Szlążek, Iwona Pudełko, Barbara Roguska
Format: Article
Language:English
Published: Kazimierz Wielki University 2025-04-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/JEHS/article/view/59348
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850258858185850880
author Adam Jan Ząbek
Jakub Paweł Kuźniar
Emilia Gabriela Chrzanowska
Michalina Zagalska
Marta Turek
Tomasz Tamborski
Adam Grzebinoga
Julia Szlążek
Iwona Pudełko
Barbara Roguska
author_facet Adam Jan Ząbek
Jakub Paweł Kuźniar
Emilia Gabriela Chrzanowska
Michalina Zagalska
Marta Turek
Tomasz Tamborski
Adam Grzebinoga
Julia Szlążek
Iwona Pudełko
Barbara Roguska
author_sort Adam Jan Ząbek
collection DOAJ
description Hydroxychloroquine (HCQ) is a long-established drug, initially used to treat malaria and later widely applied in autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). As an immunomodulatory agent, HCQ plays a crucial role in managing chronic inflammation. Despite its benefits, its use requires monitoring due to potential adverse effects, including retinopathy and myopathy.[1] Objective                                                                                                                                 This review analyzes HCQ’s role in modern medicine and public health, particularly in treating autoimmune diseases. It also examines controversies surrounding its use during the COVID-19 pandemic and its implications for medical education and health prevention. Current Knowledge                                                                                                           HCQ modulates immune responses and lysosomal function, making it effective in controlling inflammation. Although hypotheses suggested antiviral properties against SARS-CoV-2, clinical trials did not confirm its efficacy, leading to changes in treatment recommendations. Methods                                                                                                                           A literature review of 32 scientific articles was conducted using PubMed and Google Scholar, focusing on HCQ’s history, mechanism of action, and applications in medicine, public health, and education. Conclusion                                                                                                                              HCQ remains a key treatment for autoimmune diseases, though its long-term safety is still under study. Continuous research and medical education are essential for optimizing its use, including potential applications in sports and rehabilitation, where chronic inflammation affects recovery and performance.
format Article
id doaj-art-aa3b3e69650640e7bd842d68fbe48a24
institution OA Journals
issn 2391-8306
language English
publishDate 2025-04-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj-art-aa3b3e69650640e7bd842d68fbe48a242025-08-20T01:56:01ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062025-04-018010.12775/JEHS.2025.80.59348Hydroxychloroquine – Beyond Malaria: Its Role in Rheumatology and COVID-19 – A Literature ReviewAdam Jan Ząbek0https://orcid.org/0009-0003-6799-1814Jakub Paweł Kuźniar1https://orcid.org/0009-0002-6716-7502Emilia Gabriela Chrzanowska2https://orcid.org/0009-0001-6228-1878Michalina Zagalska3https://orcid.org/0009-0002-7312-0065Marta Turek4https://orcid.org/0009-0005-7713-6875Tomasz Tamborski5https://orcid.org/0009-0003-6275-1010Adam Grzebinoga6https://orcid.org/0009-0001-5983-7564Julia Szlążek7https://orcid.org/0009-0007-6977-8856Iwona Pudełko8https://orcid.org/0009-0001-6403-4141Barbara Roguska 9https://orcid.org/0009-0006-6905-7517Katowice Oncology Center: Katowice, Poland, PLThe Provincial Hospital in Bielsko-Biała Al. Armii Krajowej 101 43-316 Bielsko BiałaMedical University of Silesia, 18 Medyków Street 40-752 KatowiceIndependent Public Clinical Hospital named Andrzej Mielęcki of the Silesian Medical University in Katowice, Francuska 20-24 Street, 40-027 KatowiceIndependent Public Clinical Hospital named Andrzej Mielęcki of the Silesian Medical University in Katowice, Francuska 20-24 Street, 40-027 KatowiceCounty Hospital in Zawiercie, Miodowa street 14, 42-400University Clinical Center of Prof. K. Gibiński of the Silesian Medical University in Katowice, Medyków 14 Street, 40-752 KatowiceMedical University of Silesia, 18 Medyków Street 40-752 KatowiceUniversity Clinical Hospital in Wrocław, Borowska 213 street, 50-556 WrocławMedical University of Silesia, 18 Medyków Street 40-752 Katowice Hydroxychloroquine (HCQ) is a long-established drug, initially used to treat malaria and later widely applied in autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). As an immunomodulatory agent, HCQ plays a crucial role in managing chronic inflammation. Despite its benefits, its use requires monitoring due to potential adverse effects, including retinopathy and myopathy.[1] Objective                                                                                                                                 This review analyzes HCQ’s role in modern medicine and public health, particularly in treating autoimmune diseases. It also examines controversies surrounding its use during the COVID-19 pandemic and its implications for medical education and health prevention. Current Knowledge                                                                                                           HCQ modulates immune responses and lysosomal function, making it effective in controlling inflammation. Although hypotheses suggested antiviral properties against SARS-CoV-2, clinical trials did not confirm its efficacy, leading to changes in treatment recommendations. Methods                                                                                                                           A literature review of 32 scientific articles was conducted using PubMed and Google Scholar, focusing on HCQ’s history, mechanism of action, and applications in medicine, public health, and education. Conclusion                                                                                                                              HCQ remains a key treatment for autoimmune diseases, though its long-term safety is still under study. Continuous research and medical education are essential for optimizing its use, including potential applications in sports and rehabilitation, where chronic inflammation affects recovery and performance. https://apcz.umk.pl/JEHS/article/view/59348hydroxychloroquineHCQautoimmune diseasesrheumatoid arthritissystemic lupus erythematosusmalaria
spellingShingle Adam Jan Ząbek
Jakub Paweł Kuźniar
Emilia Gabriela Chrzanowska
Michalina Zagalska
Marta Turek
Tomasz Tamborski
Adam Grzebinoga
Julia Szlążek
Iwona Pudełko
Barbara Roguska
Hydroxychloroquine – Beyond Malaria: Its Role in Rheumatology and COVID-19 – A Literature Review
Journal of Education, Health and Sport
hydroxychloroquine
HCQ
autoimmune diseases
rheumatoid arthritis
systemic lupus erythematosus
malaria
title Hydroxychloroquine – Beyond Malaria: Its Role in Rheumatology and COVID-19 – A Literature Review
title_full Hydroxychloroquine – Beyond Malaria: Its Role in Rheumatology and COVID-19 – A Literature Review
title_fullStr Hydroxychloroquine – Beyond Malaria: Its Role in Rheumatology and COVID-19 – A Literature Review
title_full_unstemmed Hydroxychloroquine – Beyond Malaria: Its Role in Rheumatology and COVID-19 – A Literature Review
title_short Hydroxychloroquine – Beyond Malaria: Its Role in Rheumatology and COVID-19 – A Literature Review
title_sort hydroxychloroquine beyond malaria its role in rheumatology and covid 19 a literature review
topic hydroxychloroquine
HCQ
autoimmune diseases
rheumatoid arthritis
systemic lupus erythematosus
malaria
url https://apcz.umk.pl/JEHS/article/view/59348
work_keys_str_mv AT adamjanzabek hydroxychloroquinebeyondmalariaitsroleinrheumatologyandcovid19aliteraturereview
AT jakubpawełkuzniar hydroxychloroquinebeyondmalariaitsroleinrheumatologyandcovid19aliteraturereview
AT emiliagabrielachrzanowska hydroxychloroquinebeyondmalariaitsroleinrheumatologyandcovid19aliteraturereview
AT michalinazagalska hydroxychloroquinebeyondmalariaitsroleinrheumatologyandcovid19aliteraturereview
AT martaturek hydroxychloroquinebeyondmalariaitsroleinrheumatologyandcovid19aliteraturereview
AT tomasztamborski hydroxychloroquinebeyondmalariaitsroleinrheumatologyandcovid19aliteraturereview
AT adamgrzebinoga hydroxychloroquinebeyondmalariaitsroleinrheumatologyandcovid19aliteraturereview
AT juliaszlazek hydroxychloroquinebeyondmalariaitsroleinrheumatologyandcovid19aliteraturereview
AT iwonapudełko hydroxychloroquinebeyondmalariaitsroleinrheumatologyandcovid19aliteraturereview
AT barbararoguska hydroxychloroquinebeyondmalariaitsroleinrheumatologyandcovid19aliteraturereview